ACOTEC-B (06669) announced that on November 13, 2025, the group received approval from China's National Medical Products Administration (NMPA) for the registration of its coronary over-the-wire balloon dilatation catheter, Jingyi®.

Jingyi® is indicated for balloon dilatation of stenotic coronary arteries or coronary bypass graft vessels to improve myocardial perfusion. Models with balloon diameters of 2.0-5.0mm are also suitable for post-stent delivery dilatation.

As a semi-compliant balloon dilatation catheter, Jingyi® features a smaller distal tip outer diameter and folded balloon profile, along with an optimized delivery system, ensuring superior trackability and pushability. It is designed to effectively address complex lesions such as chronic total occlusions and severe calcification. The over-the-wire exchange design further enhances procedural efficiency and safety.

The company plans to initiate marketing activities in China at an appropriate time.